NovoCure NVCR Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by NovoCure in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: NovoCure’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about NovoCure's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is NovoCure's total liabilities & equity?
- NovoCure (NVCR) reported total liabilities & equity of $787.93M in Q1 2026.
- How has NovoCure's total liabilities & equity changed year-over-year?
- NovoCure's total liabilities & equity decreased by 36.9% year-over-year, from $1.25B to $787.93M.
- What is the long-term trend for NovoCure's total liabilities & equity?
- Over 5 years (2020 to 2025), NovoCure's total liabilities & equity has grown at a -5.2% compound annual growth rate (CAGR), from $1.05B to $804.33M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.